Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Rosigkeit, Sebastian; Kruchem, Marie; Thies, Dorothe et al.

Definitive evidence for Club cells as progenitors for mutant Kras/Trp53-deficient lung cancer

INTERNATIONAL JOURNAL OF CANCER. Bd. 149. H. 9. 2021 S. 1670-1682


Legscha, Kevin Jan; Ferreira, Edite Antunes; Chamoun, Antonios et al.

Delta 133p53 alpha enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

JOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 9. H. 6. 2021


Oldenburg, Johannes; Klamroth, Robert; Langer, Florian et al.

Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH

HAMOSTASEOLOGIE. Bd. 41. H. 03. 2021 S. 184-189




Faehling, Martin; Schumann, Christian; Christopoulos, Petros et al.

Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP

DATA IN BRIEF. Bd. 34. 2021


Woods, Kevin; Guezguez, Borhane

Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and Leukemia

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. Bd. 9. 2021


Woods, Kevin; Guezguez, Borhane

Dynamic Changes of the Bone Marrow Niche: Mesenchymal Stromal Cells and Their Progeny During Aging and Leukemia

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. Bd. 9. 2021


Guezguez, Borhane

Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies

CURRENT OPINION IN HEMATOLOGY. Bd. 28. H. 5. 2021 S. 345-346


Saalfeld, Felix C.; Wenzel, Carina; Christopoulos, Petros et al.

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

JOURNAL OF THORACIC ONCOLOGY. Bd. 16. H. 11. 2021 S. 1952-1958